Diederik Hentenaar
46 Chapter 2 REFERENCES Alassy, H., Parachuru, P. (2019). Wolff L. Peri-Implantitis Diagnosis and Prognosis Using Biomarkers in Peri-Implant Crevicular Fluid: A Narrative Review. Diagnostics (Basel) , 9:214. doi:10.3390/ diagnostics9040214 Al-Majid, A., Alassiri, S., Rathnayake, N., Tervahartiala, T., Gieselmann, DR., Sorsa, T. (2018). Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri- Implant Diseases. International Journal of Dentistry , 7891323. doi:10.1155/2018/7891323 Arikan, F., Buduneli, N., Lappin, D.F. (2011). C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri- implantitis: a case-control study. International Journal of Oral and Maxillofacial Implants , 26:282–289. Armitage, G.C. (2004). Analysis of gingival crevice fluid and risk of progression of periodontitis. Periodontology 2000 , 34:109–119. doi:10.1046/j.0906-6713.2002.003427.x Apse, P., Ellen, R.P., Overall, C.M., Zarb, G.A. (1989). Microbiota and crevicular fluid collagenase activity in the osseointegrated dental implant sulcus: a comparison of sites in edentulous and partially edentulous patients. Journal of Periodontal Research , 24:96–105. doi:10.1111/j.1600-0765.1989.tb00863.x Ata-Ali, J., Flichy-Fernández, A.J., Alegre-Domingo, T., Ata-Ali, F., Peñarrocha-Diago M. (2016). Impact of heavy smoking on the clinical, microbiological and immunological parameters of patients with dental implants: a prospective cross-sectional study. Journal of Investigative and Clinical Dentistry , 7:401–409. doi:10.1111/jicd.12176 Bassetti M., Schär D., Wicki B., et al. (2014). Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: 12-month outcomes of a randomized controlled clinical trial. Clinical Oral Implants Research , 25:279–287. doi:10.1111/clr.12155 Bhavsar, I., Miller, C.S., Ebersole, J.L. Dawson, D.R. 3rd, Thompson, K.L., Al-Sabbagh, M. (2019). Biological response to peri-implantitis treatment. Journal of Periodontal Research , 54:720–728. doi:10.1111/jre.12681 Bordin, S., Flemmig, T.F., Verardi, S. (2009). Role of fibroblast populations in peri-implantitis. International Journal of Oral and Maxillofacial Implants , 24:197–204. Carinci, F., Romanos, G.E., Scapoli, L. (2019). Molecular tools for preventing and improving diagnosis of peri-implant diseases. Periodontology 2000 , 2019;81(1):41–47. doi:10.1111/prd.12281 Chan, A.W., Tetzlaff, J.M., Altman, D.G. (2013). SPIRIT 2013 statement: defining standard protocol items for clinical trials. Annas of Internal Medicine , 158:200–207. doi:10.7326/0003-4819-158-3- 201302050-00583
Made with FlippingBook
RkJQdWJsaXNoZXIy ODAyMDc0